Ai-guided radiation planning for stomach lymphoma
Part of Cancer, Immune system & allergy clinical trials.
This study tests whether artificial intelligence can help make radiation therapy more precise for stomach lymphoma. The goal is to improve treatment by adjusting the radiation plan each day based on your body's changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are in good general health, able to carry out daily activities (doctor's rating of 0 or 1).
- You have been diagnosed with primary gastric lymphoma (stage I, II, or IIE).
- Your doctors agree that radiation therapy is a good option for you, either as the main treatment or after chemotherapy.
- Your major organs (like bone marrow, liver, kidneys, and heart) are working well enough.
- You have not had prior radiation to the belly or pelvic area within the last 3 years, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a low dose of radiation and an oral targeted drug (orelabrutinib) for people with early-stage MALT lymphoma. The goal is to see if adjusting the treatment based on your response can be effective and reduce side effects.
This trial is testing a new combination treatment for advanced or metastatic stomach cancer (that is MSS/pMMR and HER2-negative) that has not been treated before. The treatment combines a short course of radiation (targeted to lymph nodes) with first-line therapy and a PD-1 inhibitor (a type of immunotherapy) to see if it can help control the cancer and improve outcomes.
This study uses an AI tool to help plan how doctors deliver focused radiation to lung tumors. It may help make radiation targeting more precise and support treatment safety for people with primary or limited metastatic lung cancer.
This study uses artificial intelligence to analyze your CT scan and predict whether stomach cancer has spread to lymph nodes behind your belly. The goal is to help doctors decide if you need more extensive surgery.
This study uses artificial intelligence to predict whether stomach cancer has spread to nearby lymph nodes. By analyzing your CT/MRI scans and biopsy results before surgery, the AI may help doctors plan your treatment more precisely.
This trial is testing a new artificial intelligence (AI) model to help doctors better identify whether gastric cancer has spread to nearby lymph nodes. If you qualify, you may help improve how this cancer is diagnosed and treated, without any extra invasive procedures.
Hear when a new Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.